Dragon Ball creator Akira Toriyama wanted to end the series, but kept going under one condition. So, here's what you need to ...
In honor of Rare Disease Day, the Celtics are teaming with Takeda Pharmaceuticals to raise awareness and support for the rare disease community.
For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
Here are today's five things you need to know, including Dana-Farber, Beth Israel, life sciences jobs, rare diseases and flying zebras.
A network of public and private sector partners, non-governmental organizations (NGOs), academic institutions, patient ...
Check out new production photos for The Public Theater and Ma-Yi Theater Company’s New York premiere of SUMO, a new play ...
Grifols revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential ...
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
(HealthDay News) — Maternal health in pregnancy is associated with offspring autism, and these associations are largely attributed to familial confounding, according to a study published online Jan.
The efforts over the past year by the team at Keros have positioned us to continue to advance our promising pipeline of novel therapeutics,” said Jasbir S. Seehra, Ph.D., Chair and Chief Executive ...
In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...
2d
Hosted on MSNTakeda broadens its deal with BridGene for up to $770mBridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology. Takeda will pay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results